Cell Reports (Dec 2017)

Soluble Prefusion Closed DS-SOSIP.664-Env Trimers of Diverse HIV-1 Strains

  • M. Gordon Joyce,
  • Ivelin S. Georgiev,
  • Yongping Yang,
  • Aliaksandr Druz,
  • Hui Geng,
  • Gwo-Yu Chuang,
  • Young Do Kwon,
  • Marie Pancera,
  • Reda Rawi,
  • Mallika Sastry,
  • Guillaume B.E. Stewart-Jones,
  • Angela Zheng,
  • Tongqing Zhou,
  • Misook Choe,
  • Joseph G. Van Galen,
  • Rita E. Chen,
  • Christopher R. Lees,
  • Sandeep Narpala,
  • Michael Chambers,
  • Yaroslav Tsybovsky,
  • Ulrich Baxa,
  • Adrian B. McDermott,
  • John R. Mascola,
  • Peter D. Kwong

Journal volume & issue
Vol. 21, no. 10
pp. 2992 – 3002

Abstract

Read online

Summary: The elicitation of autologous neutralizing responses by immunization with HIV-1 envelope (Env) trimers conformationally stabilized in a prefusion closed state has generated considerable interest in the HIV-1 vaccine field. However, soluble prefusion closed Env trimers have been produced from only a handful of HIV-1 strains, limiting their utility as vaccine antigens and B cell probes. Here, we report the engineering from 81 HIV-1 strains of soluble, fully cleaved, prefusion Env trimers with appropriate antigenicity. We used a 96-well expression-screening format to assess the ability of artificial disulfides and Ile559Pro substitution (DS-SOSIP) to produce soluble cleaved-Env trimers; from 180 Env strains, 20 yielded prefusion closed trimers. We also created chimeras, by utilizing structure-based design to incorporate select regions from the well-behaved BG505 strain; from 180 Env strains, 78 DS-SOSIP-stabilized chimeras, including 61 additional strains, yielded prefusion closed trimers. Structure-based design thus enables the production of prefusion closed HIV-1-Env trimers from dozens of diverse strains. : Joyce et al. use a structure-based chimeric strategy to produce prefusion closed Env trimers from 81 strains of HIV-1 encompassing all major clades. These soluble Env trimers should have utility as B cell probes and HIV-1 immunogens, thereby enabling both antibody identification and vaccine development. Keywords: conformational stabilization, envelope trimer, HIV-1 vaccine, prefusion closed trimer, structure-based design